SOPHiA GENETICS (SOPH) Debt to Equity (2020 - 2025)
SOPHiA GENETICS recorded quarterly Debt to Equity of -$0.6 in Q4 2025, down 185.26% quarter-over-quarter from -$0.21 in Q4 2024, and down 185.26% year-over-year from $0.71 in Q4 2024.
SOPHiA GENETICS's Debt to Equity history runs 3 years deep, the most recent figure standing at -$0.6 for Q4 2025.
- In Q4 2025, Debt to Equity fell 185.26% year-over-year to -$0.6; the TTM figure through Dec 2025 stood at -$0.6 (down 185.26% YoY), while the FY2025 annual figure was -$0.6, down 185.26% from the prior year.
- Debt to Equity came in at -$0.6 for Q4 2025 at SOPHiA GENETICS, down from -$0.21 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of -$0.21 in Q4 2024 to a low of -$0.6 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 1.26 |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 0.46 |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 0.37 |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | SOPHiA GENETICS | 24.12 Mn | -46.17 Mn | 14.69 Mn | -0.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.60 |
| Dec 31, 2024 | -0.21 |
| Dec 31, 2020 | -0.08 |